Know Your Investor (April Edition): OrbiMed Advisors
Shots: An American investment firm, OrbiMed Advisor is a prominent name when it co...
Insights+: EMA Marketing Authorization of New Drugs in March 2024
Shots: The EC approved 1 Biologic and 11 New Chemical Entities in March 2024, leading t...
Disease of the Month - Duchenne Muscular Dystrophy (DMD)
Shots: The Disease of the Month report by PharmaShots aims to integrat...
Insights+: The US FDA New Drug Approvals in March 2024
Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month...
Insights+ Key Biosimilars Events of March 2024
Shots: Biosimilars are developed to be highly similar versions o...
PharmaShots' Key Highlights of First Quarter 2024
Shots: The first quarter of 2024 highlights major acquisitions in the pharma and b...
